Phentermine vs Semaglutide: What’s the Difference?

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider regarding any medical condition or treatment.

Key Takeaways

  • Phentermine is a sympathomimetic stimulant FDA-approved only for short-term (12-week) weight loss; semaglutide is approved for chronic long-term weight management.
  • Average weight loss is roughly 5 percent body weight on phentermine alone vs 15 percent on semaglutide at maximum dose.
  • Phentermine works through appetite suppression via central nervous system stimulation; semaglutide works through gut hormone signaling.
  • Phentermine costs less ($30-$80 per month generic) than semaglutide (~$1,349 monthly for Wegovy) but is much less effective.
  • The two are sometimes used together off-label, though combination data are limited.

Phentermine and semaglutide are both weight-loss medications but operate by very different mechanisms, have very different efficacy profiles, and are used for very different durations. Phentermine is a stimulant approved for short-term (12-week) weight loss with modest average results (~5% body weight). Semaglutide is a GLP-1 receptor agonist approved for chronic long-term weight management with substantially larger results (~15% body weight loss). Below is a head-to-head comparison.

How Each Drug Works

Phentermine is a sympathomimetic amine — a central nervous system stimulant chemically related to amphetamines but with weaker stimulant effects. It works primarily by:

  • Stimulating release of norepinephrine in the brain
  • Activating the sympathetic nervous system (fight-or-flight response)
  • Suppressing appetite via central nervous system effects
  • Slightly increasing metabolic rate

Semaglutide is a GLP-1 receptor agonist — a peptide that mimics the natural gut hormone GLP-1. It works through:

  • Activating GLP-1 receptors in the pancreas, gut, and brain
  • Slowing gastric emptying (food stays in stomach longer)
  • Reducing appetite via brain satiety signals
  • Improving insulin secretion in response to glucose

Efficacy Comparison

Outcome Phentermine Semaglutide (Wegovy)
Approved duration Short-term (≤12 weeks) Chronic / long-term
Average weight loss ~5% body weight ~15% body weight (at 68 weeks)
Pounds lost (for 220-lb starting) ~11 lbs ~33 lbs
Time to maximum effect 4-12 weeks 17-68 weeks
Sustained weight loss after stopping Often regained Most regained without continued use

Side Effects: Very Different Profiles

Phentermine side effects:

  • Increased heart rate (often 10-20 bpm)
  • Elevated blood pressure
  • Insomnia (especially if taken later in day)
  • Dry mouth
  • Jitteriness, anxiety
  • Headache
  • Constipation
  • Heart palpitations

Semaglutide side effects:

  • Nausea (~44%)
  • Diarrhea (~30%)
  • Constipation (~24%)
  • Vomiting (~24%)
  • Abdominal pain (~20%)
  • Fatigue (~11%)
  • Hair loss (rare, temporary)

The profiles are essentially non-overlapping. Phentermine causes stimulant-related effects; semaglutide causes gastrointestinal effects.

Cardiovascular Considerations

Phentermine is contraindicated in patients with:

  • Heart disease (coronary artery disease, heart failure, arrhythmias)
  • Uncontrolled hypertension
  • Hyperthyroidism
  • Glaucoma
  • History of substance abuse
  • Pregnancy

The stimulant effects can dangerously increase cardiovascular workload in patients with underlying heart conditions.

Semaglutide has cardiovascular cautions (modest heart rate increase, ~1-4 bpm) but is generally considered safer in cardiac patients. Wegovy has FDA approval for cardiovascular risk reduction in adults with cardiovascular disease and obesity — the opposite cardiovascular implication from phentermine.

Cost Comparison

Product Form Monthly Cost (approximate)
Generic phentermine Tablet or capsule (daily) $30-$80
Brand phentermine (Adipex-P, Lomaira) Tablet (daily) $100-$200
Wegovy Weekly injection ~$1,349
Ozempic (off-label for weight loss) Weekly injection ~$968

The cost difference is substantial — phentermine costs 10-40x less than semaglutide before insurance. Insurance coverage rules differ too: phentermine is often covered for short-term use; semaglutide is more variably covered for weight loss.

Duration of Use

Phentermine is FDA-approved only for short-term use (a “few weeks,” typically interpreted as up to 12 weeks). Long-term use is off-label and carries risks of:

  • Tolerance development (effect diminishes over time)
  • Psychological dependence
  • Cardiovascular strain from chronic stimulant exposure
  • Insomnia and sleep disruption

Semaglutide is approved for chronic long-term use, including indefinite continuation if weight loss is maintained and tolerated. The drug works long-term without tolerance and is generally well-tolerated chronically.

Sustainability of Weight Loss

Both drugs typically show weight regain after discontinuation. The “weight” of this is different:

  • Phentermine: limited weight loss to begin with, so limited regain
  • Semaglutide: substantial weight loss; most patients regain most of the lost weight within 1-2 years of discontinuation unless lifestyle changes are very strong

Both are most effective when combined with lifestyle modification (diet, exercise) and may need to be continued long-term for sustained weight loss.

Combination Use (Off-Label)

Some prescribers use phentermine and semaglutide together off-label. The combination has not been studied in major clinical trials and is not FDA-approved. Theoretical considerations:

  • Different mechanisms could produce additive weight loss
  • Different side-effect profiles could be more tolerable than maxing either alone
  • Increased cardiovascular workload from combined stimulant + GI effects
  • Limited published safety data on long-term combination use

Discuss with your prescriber before combining; this is not a standard combination approach.

Which Should You Choose?

For most patients:

  • Phentermine is appropriate for: short-term weight loss jump-start, cost-constrained patients without GLP-1 coverage, patients without cardiac contraindications
  • Semaglutide is appropriate for: patients seeking substantial long-term weight loss, patients with type 2 diabetes, patients with cardiovascular disease (where Wegovy has approved CV risk reduction)

The two drugs occupy different positions in the obesity treatment landscape. They are not direct substitutes — they have different durations, different mechanisms, very different efficacy, and very different costs.

The Bottom Line

Phentermine and semaglutide are very different drugs. Phentermine is a short-term stimulant with modest weight loss (~5%); semaglutide is a chronic GLP-1 agonist with substantial weight loss (~15%). Phentermine costs much less but is much less effective and is limited to short-term use. Semaglutide is the more effective option for sustained weight management but comes at higher cost and with different side effects. Discuss with your prescriber which fits your specific situation. For more on weight-loss treatment options, see our hub.

Frequently Asked Questions

Is phentermine or semaglutide more effective for weight loss?

Semaglutide produces substantially more weight loss on average — about 15 percent body weight reduction at maximum dose over 68 weeks (STEP-1 trial) compared to about 5 percent for phentermine alone over 12 weeks. Semaglutide is also approved for long-term use, while phentermine is only approved for short-term (12 weeks at most).

Can you take phentermine and semaglutide together?

Some prescribers use the combination off-label, but no FDA-approved combination exists. Limited research is available on combined efficacy and safety. The stimulant effects of phentermine combined with the slowed gastric emptying of semaglutide could theoretically increase cardiovascular workload. Discuss with your prescriber before combining.

Is phentermine cheaper than semaglutide?

Yes, substantially. Generic phentermine costs $30-$80 per month before insurance; brand-name semaglutide costs $968-$1,349 per month. Phentermine is also more often covered by insurance for short-term use. The cost difference is significant for patients without coverage for GLP-1 drugs.

Are phentermine side effects worse than semaglutide?

Different profiles. Phentermine commonly causes increased heart rate, insomnia, dry mouth, jitteriness, headache, and elevated blood pressure. Semaglutide commonly causes nausea, constipation, diarrhea, and vomiting. Phentermine has more cardiovascular cautions (contraindicated in many patients with heart disease); semaglutide has the FDA boxed warning about thyroid C-cell tumors.

Is phentermine addictive?

Phentermine is a controlled substance (Schedule IV in the US) with potential for psychological dependence, especially with longer-term use. This is part of why it's only approved for short-term use. Semaglutide is not a controlled substance and has no documented addiction potential — appetite returns to normal after discontinuation.

Sources

  1. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers
  2. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
  3. https://diabetes.org/about-diabetes/medication-management
  4. https://www.cdc.gov/diabetes/treatment/